TRINOVA HEALTH Trademark

Trademark Overview


On Wednesday, July 10, 2024, a trademark application was filed for TRINOVA HEALTH with the United States Patent and Trademark Office. The USPTO has given the TRINOVA HEALTH trademark a serial number of 98642114. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, January 27, 2025. This trademark is owned by Sizent LLC. The TRINOVA HEALTH trademark is filed in the Advertising, Business and Retail Services category with the following description:

Retail pharmacy services
trinova health

General Information


Serial Number98642114
Word MarkTRINOVA HEALTH
Filing DateWednesday, July 10, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, January 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkTRI NOVA HEALTH
Goods and ServicesRetail pharmacy services
NOT AVAILABLEHEALTH

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, July 10, 2024
Primary Code035
First Use Anywhere DateMonday, June 1, 2015
First Use In Commerce DateMonday, June 1, 2015

Trademark Owner History


Party NameSizent LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressTAMPA, FL 33619

Trademark Events


Event DateEvent Description
Wednesday, January 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 24, 2025ASSIGNED TO EXAMINER
Monday, January 27, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 27, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 10, 2024NEW APPLICATION ENTERED
Monday, January 27, 2025NON-FINAL ACTION E-MAILED
Monday, January 27, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 27, 2025NON-FINAL ACTION WRITTEN
Monday, January 27, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED